Cargando…
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
Basigin, or CD147, has been reported as a coreceptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to invade host cells. Basigin also has a well-established role in Plasmodium falciparum malaria infection of human erythrocytes, where it is bound by one of the parasite’s invasi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386461/ https://www.ncbi.nlm.nih.gov/pubmed/34378982 http://dx.doi.org/10.1128/mSphere.00647-21 |
_version_ | 1783742267398291456 |
---|---|
author | Ragotte, Robert J. Pulido, David Donnellan, Francesca R. Hill, Michelle L. Gorini, Giacomo Davies, Hannah Brun, Juliane McHugh, Kirsty King, Lloyd D. W. Skinner, Katherine Miura, Kazutoyo Long, Carole A. Zitzmann, Nicole Draper, Simon J. |
author_facet | Ragotte, Robert J. Pulido, David Donnellan, Francesca R. Hill, Michelle L. Gorini, Giacomo Davies, Hannah Brun, Juliane McHugh, Kirsty King, Lloyd D. W. Skinner, Katherine Miura, Kazutoyo Long, Carole A. Zitzmann, Nicole Draper, Simon J. |
author_sort | Ragotte, Robert J. |
collection | PubMed |
description | Basigin, or CD147, has been reported as a coreceptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to invade host cells. Basigin also has a well-established role in Plasmodium falciparum malaria infection of human erythrocytes, where it is bound by one of the parasite’s invasion ligands, reticulocyte binding protein homolog 5 (RH5). Here, we sought to validate the claim that the receptor binding domain (RBD) of SARS-CoV-2 spike glycoprotein can form a complex with basigin, using RH5-basigin as a positive control. Using recombinantly expressed proteins, size exclusion chromatography and surface plasmon resonance, we show that neither RBD nor full-length spike glycoprotein bind to recombinant human basigin (expressed in either Escherichia coli or mammalian cells). Further, polyclonal anti-basigin IgG did not block SARS-CoV-2 infection of Vero E6 cells. Given the immense interest in SARS-CoV-2 therapeutic targets to improve treatment options for those who become seriously ill with coronavirus disease 2019 (COVID-19), we would caution the inclusion of basigin in this list on the basis of its reported direct interaction with SARS-CoV-2 spike glycoprotein. IMPORTANCE Reducing the mortality and morbidity associated with COVID-19 remains a global health priority. Vaccines have proven highly effective at preventing infection and hospitalization, but efforts must continue to improve treatment options for those who still become seriously ill. Critical to these efforts is the identification of host factors that are essential to viral entry and replication. Basigin, or CD147, was previously identified as a possible therapeutic target based on the observation that it may act as a coreceptor for SARS-CoV-2, binding to the receptor binding domain of the spike protein. Here, we show that there is no direct interaction between the RBD and basigin, casting doubt on its role as a coreceptor and plausibility as a therapeutic target. |
format | Online Article Text |
id | pubmed-8386461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-83864612021-09-09 Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein Ragotte, Robert J. Pulido, David Donnellan, Francesca R. Hill, Michelle L. Gorini, Giacomo Davies, Hannah Brun, Juliane McHugh, Kirsty King, Lloyd D. W. Skinner, Katherine Miura, Kazutoyo Long, Carole A. Zitzmann, Nicole Draper, Simon J. mSphere Research Article Basigin, or CD147, has been reported as a coreceptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to invade host cells. Basigin also has a well-established role in Plasmodium falciparum malaria infection of human erythrocytes, where it is bound by one of the parasite’s invasion ligands, reticulocyte binding protein homolog 5 (RH5). Here, we sought to validate the claim that the receptor binding domain (RBD) of SARS-CoV-2 spike glycoprotein can form a complex with basigin, using RH5-basigin as a positive control. Using recombinantly expressed proteins, size exclusion chromatography and surface plasmon resonance, we show that neither RBD nor full-length spike glycoprotein bind to recombinant human basigin (expressed in either Escherichia coli or mammalian cells). Further, polyclonal anti-basigin IgG did not block SARS-CoV-2 infection of Vero E6 cells. Given the immense interest in SARS-CoV-2 therapeutic targets to improve treatment options for those who become seriously ill with coronavirus disease 2019 (COVID-19), we would caution the inclusion of basigin in this list on the basis of its reported direct interaction with SARS-CoV-2 spike glycoprotein. IMPORTANCE Reducing the mortality and morbidity associated with COVID-19 remains a global health priority. Vaccines have proven highly effective at preventing infection and hospitalization, but efforts must continue to improve treatment options for those who still become seriously ill. Critical to these efforts is the identification of host factors that are essential to viral entry and replication. Basigin, or CD147, was previously identified as a possible therapeutic target based on the observation that it may act as a coreceptor for SARS-CoV-2, binding to the receptor binding domain of the spike protein. Here, we show that there is no direct interaction between the RBD and basigin, casting doubt on its role as a coreceptor and plausibility as a therapeutic target. American Society for Microbiology 2021-08-11 /pmc/articles/PMC8386461/ /pubmed/34378982 http://dx.doi.org/10.1128/mSphere.00647-21 Text en Copyright © 2021 Ragotte et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Ragotte, Robert J. Pulido, David Donnellan, Francesca R. Hill, Michelle L. Gorini, Giacomo Davies, Hannah Brun, Juliane McHugh, Kirsty King, Lloyd D. W. Skinner, Katherine Miura, Kazutoyo Long, Carole A. Zitzmann, Nicole Draper, Simon J. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
title | Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
title_full | Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
title_fullStr | Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
title_full_unstemmed | Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
title_short | Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein |
title_sort | human basigin (cd147) does not directly interact with sars-cov-2 spike glycoprotein |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386461/ https://www.ncbi.nlm.nih.gov/pubmed/34378982 http://dx.doi.org/10.1128/mSphere.00647-21 |
work_keys_str_mv | AT ragotterobertj humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT pulidodavid humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT donnellanfrancescar humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT hillmichellel humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT gorinigiacomo humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT davieshannah humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT brunjuliane humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT mchughkirsty humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT kinglloyddw humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT skinnerkatherine humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT miurakazutoyo humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT longcarolea humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT zitzmannnicole humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein AT drapersimonj humanbasigincd147doesnotdirectlyinteractwithsarscov2spikeglycoprotein |